Cancer Research

Merck KGaA And Idera Pharmaceuticals To Collaborate On Development Of TLR9 Agonists For Treatment Of Cancer

GENEVA, Switzerland, December 19 /PRNewswire/-- Merck KGaA announced today that it has entered into a worldwide licensing and collaboration agreement on behalf of its Merck Serono division with Idera Pharmaceuticals, Inc. of Cambridge, Massachusetts, USA ...

Article - Anna Ohlden - Dec 19 2007 - 7:30am

“Brain Signature” For Cigarette Cravings Identified

A new brain imaging study by researchers in the Abramson Cancer Center of the University of Pennsylvania shows that cigarette cravings in smokers who are deprived of nicotine are linked with increased activation in specific regions of the brain. Using a no ...

Article - News Staff - Dec 19 2007 - 11:46am

'Inefficient' Cell Replacement Prevents Cancer, Says Study

The seemingly inefficient way our bodies replace worn-out cells is a defense against cancer, according to new research. Having the neighboring cell just split into two identical daughter cells would seem to be the simplest way to keep bodies from falling a ...

Article - News Staff - Dec 19 2007 - 6:44pm

Merck Serono And Flamel To Collaborate On An Extended Release Formulation For Therapeutic Proteins

GENEVA, Switzerland, December 20 /PRNewswire/--- Flamel's Medusa(R) Technology Designed to Allow Less Frequent Administration of Therapeutic Proteins and Peptides ...

Article - Anna Ohlden - Dec 20 2007 - 3:30am

MedImmune Expands Scientific And Engineering Leadership

GAITHERSBURG, Maryland, December 20 /PRNewswire/--- Company also Establishes New Site Leadership Team at Cambridge Facility Continuing the solidification of its role as the global biologics unit for AstraZeneca plc (AZ), MedImmune today announced that And ...

Article - Anna Ohlden - Dec 20 2007 - 11:30am

Abbott's HUMIRA(R) Approved In The European Union For Treatment Of Moderate-to-Severe Plaque Psoriasis

ABBOTT PARK, Illinois, December 20 /PRNewswire/--- In Clinical Trials, Patients Taking HUMIRA Saw Significant and Sustained Skin Clearance ...

Article - Anna Ohlden - Dec 20 2007 - 2:30pm

SCIENCE Announces Its Discovery Of The Year: Human Genetic Variation

In 2007, researchers were dazzled by the degree to which genomes differ from one human to another and began to understand the role of these variations in disease and personal traits. Science and its publisher, AAAS, the nonprofit science society, recognize ...

Article - News Staff - Dec 20 2007 - 5:25pm

Oncolytics Biotech Inc. Completes Patient Enrolment In U.K. Phase Ia/Ib Combination REOLYSIN(R)/Radiation Clinical Trial

CALGARY, Canada, December 21 /PRNewswire/-- Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC) (NASDAQ:ONCY) has completed patient enrolment in its Phase Ia/Ib U.K. clinical trial investigating the intratumoural delivery of REOLYSIN(R) in combinat ...

Article - Anna Ohlden - Dec 21 2007 - 12:30pm

Culinary Surprise: Cooking Can Preserve And Even Boost Nutrient Content Of Vegetables

In a finding that defies conventional culinary wisdom, researchers in Italy report that cooking vegetables can preserve or even boost their nutritional value in comparison to their raw counterparts, depending on the cooking method used. Their study is sche ...

Article - News Staff - Dec 24 2007 - 11:24am

Progress Toward Reversing Cirrhosis And Other Liver Diseases

University of California, San Diego researchers have proven in animal studies that fibrosis in the liver can be not only stopped, but reversed. Their discovery, published in PLoS Online, opens the door to treating and curing conditions that lead to excessi ...

Article - News Staff - Dec 26 2007 - 9:06pm